Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...
Dr. Christine Allen, Co-Founder and CEO of Intrepid Labs, and Dr. Andrew Lewis, Chief Scientific Officer of Quotient Sciences, explain how AI can be used in drug development to shorten development ...
Pharmaceutical and biopharmaceutical laboratories increasingly need to characterize complex samples that contain APIs, ...
Lipid nanoparticle formulation has increased over the past two decades. LNPs have proven to be effective nano-based delivery vehicles for cytotoxic chemotherapeutic drugs, nucleic acid therapies and ...
Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design that better anticipates manufacturability ...
Along with fellow LNP Alliance members, NOF Corporation and Neosome Life Sciences, Phosphorex is hosting a free, one-hour virtual discussion entitled, "Streamline Targeted LNP Development to Improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results